Safe Implant Technology ApS: Financial statements 2020
CVR: 38969153
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Safe Implant Technology ApS (CVR 38969153) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,125 and a net result of DKK -3,125 compared with DKK -3,125 the year before. Equity in the 2020 report amounted to DKK 40,625. The solvency ratio was 10.3%.
- Gross Profit
- DKK -3,125
- Profit/Loss
- DKK -3,125
- Equity
- DKK 40,625
- Total Assets
- DKK 392,975
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -3 t. | -3 t. | 41 t. | 0 |
| 2019 | - | -3 t. | -3 t. | 44 t. | 0 |
Official annual report
How creditworthy is Safe Implant Technology ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Safe Implant Technology ApS has published its annual report for 2019. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
About Safe Implant Technology ApS
Safe Implant Technology ApS is a Danish company of the type Anpartsselskab based in Fårevejle, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Nakskov. The board consists of Søren Luplau-Pagh (chair), Gorm Danscher, Henrik Nakskov and Lone Damgaard Horup. The company is owned by BERLOCK ApS and Devopharma ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 756,423 and a net result of DKK -53,855 compared with DKK -724,511 the year before. Equity in the 2025 report amounted to DKK -946,258.